|
|
Other links at Articles > Hematology-Oncology |
| 3. |
FDA Safety Changes: Campath and Trileptal
|
|
|
The FDA has approved revisions to the safety labeling for alemtuzumab intravenous injection (Campath) and oxcarbazepine tablets/oral suspension (Trileptal). Medscape Medical News
|
| 4. |
New Insights Into Molecular Mechanisms of Cisplatin DNA
|
|
|
Researchers identify how cells cope with damage caused by cisplatin during chemotherapy treatment, revealing that lesions in the DNA caused by cisplatin lead to stalling of the transcription machine and subsequent removal of the lesion. Medscape Medical News
|
|
|